CERS:NASDAQ
Cerus Corp
US$2,28
arrow_downward
-0,44%(-0,0100) 1D
US$2,28
0,00% (0,00)
bedtimeAfter hours
Closed: 8 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CERS...
Open
US$2,26
High
US$2,29
Low
US$2,20
Mkt. cap
459,48 ລ້ານ
Avg. vol.
1,61 ລ້ານ
Volume
2,42 ລ້ານ
52-wk high
US$3,47
52-wk low
US$1,38
EPS
US$-0,03
Beta
1,83
Shares outstanding
201,52 ລ້ານ
No. of employees
268
Open
US$2,26
High
US$2,29
Low
US$2,20
Mkt. cap
459,48 ລ້ານ
Avg. vol.
1,61 ລ້ານ
Volume
2,42 ລ້ານ
52-wk high
US$3,47
52-wk low
US$1,38
EPS
US$-0,03
Beta
1,83
Shares outstanding
201,52 ລ້ານ
No. of employees
268
News stories
From web sources and news partners
Simply Wall Street
·
4 ນາທີກ່ອນ
Does AST SpaceMobile (ASTS) Canada Test Change The Direct To Device Story?
www.marketscreener.com
·
1 ຊົ່ວໂມງກ່ອນ
RoboStrategy to Host Robotics Founders Forum and Ring the Nasdaq Closing Bell with Dyna Robotics Humanoid on October 13
Quiver Quantitative
·
15 ນາທີກ່ອນ
Veea Resolves Remaining Nasdaq Governance Deficiencies and Regains Full Listing Compliance
Yahoo Finance
·
41 ນາທີກ່ອນ
XLG Cuts the S&P 500 Down to 50 Stocks. The Result Is an Index Fund Built Entirely Around Mega-Caps
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
Foundedກ.ຍ. 1991
HeadquartersConcord, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorMedical device
Websitecerus.com